Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

World scientific leaders gather in Espoo to accelerate development of bioactive paper

24.06.2008
New methods are being developed in Finland, under VTT’s direction, for the economical mass production of bioactive paper products, among others based on printing technology.

The development is accelerated by organizing a joint conference with Canada’s SENTINEL Bioactive Paper Network. The objective of both networks is to develop completely new types of products which e.g. detect and deactivate pathogens like salmonella and SARS.

The cooperation between the Finnish and Canadian networks will be promoted in the conference, which runs from June 24-26, 2008 in Espoo. Nearly 40 representatives of SENTINEL Bioactive Paper Network are joining with the respective amount of Finnish network representatives. The focus of the conference is to find solutions to some of the technical challenges that still exist and on accelerating the development of commercial applications.

SENTINEL’s scientific director, and the professor of chemical engineering in Canada Research Chair in Interfacial Technologies and at McMaster University Robert Pelton mentions that one possible application could be for instance a strip of paper which could immediately identify the presence of contaminates in drinking water.

... more about:
»Conference »bioactive

According to Tomi Erho, Senior Rsearch Scientist at VTT, this conference marks an important milestone in developing new bioactive paper products. By joining the forces of a large group of highly skilled researchers and by sharing knowledge and skills, the research parties believe to progress faster towards their goal. Customers may have access to the first simple applications within five years.

Bioactive paper is a product that includes functionalities based on the selective reactions of biomolecules, such as enzymes or antibodies. The application possibilities are extensive and less expensive than products that are in the market today. They consist of e.g. indicators or sensors attached to filters, food product packaging or personal health diagnostics. In printed intelligence applications, the paper’s competitiveness lies in the fact that it is biodegradable, which is important in terms of sustainable development.

The project involves a network of research partners, including Åbo Akademi, HUT and the University of Lapland. It is funded by Tekes, VTT and UPM-Kymmene Oyj, Tervakoski Oy, Ciba Finland Oy, Hansaprint Oy, Oy Medix Biochemica Ab, Orion Diagnostica Oy, Starcke Oy Securities ja Eagle Filter Oy. The project will end in the spring of 2009. SENTINEL –network’s industrial partners include e.g. Ahlstrom, FUJIFILM Dimatix, Sun Chemical and Cascades.

The Finnish project is one of the key projects of the Center for Printed Intelligence, initiated by VTT in 2006. The center’s purpose is to introduce new innovations and market initiatives between the traditional ICT and paper industries by combining IT, electronics and printing technologies. The goal is to promote the commercialisation of products and to create new business aimed at the global markets.

Further information:

VTT
Senior Research Scientist, team leader Tomi Erho
Tel. +358 20 722 5671
tomi.erho@vtt.fi
Further information on VTT:
Senior Vice President
Olli Ernvall
Tel. +358 20 722 6747
olli.ernvall@vtt.fi
VTT Technical Research Centre of Finland is the biggest contract research organization in Northern Europe. VTT provides high-end technology solutions and innovation services. From its wide knowledge base, VTT can combine different technologies, create new innovations and a substantial range of world-class technologies and applied research services, thus improving its clients' competitiveness and competence. Through its international scientific and technology network, VTT can produce information, upgrade technology knowledge and create business intelligence and value added to its stakeholders.

Olli Ernvall | VTT
Further information:
http://www.sentinelbioactivepaper.ca/
http://www.vtt.fi/?lang=en

Further reports about: Conference bioactive

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
21.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New bioimaging technique is fast and economical

21.08.2017 | Medical Engineering

Silk could improve sensitivity, flexibility of wearable body sensors

21.08.2017 | Materials Sciences

On the way to developing a new active ingredient against chronic infections

21.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>